Brief: Cann Group Says Acquisition Of Zalm Therapeutics By Rua Bioscience Approved By Rua Shareholders
20/01/2022 02:11
Jan 20 (Reuters) - Cann Group Ltd CAN.AX :
* ACQUISITION OF ZALM THERAPEUTICS BY RUA BIOSCIENCE LTD
APPROVED
BY RUA'S SHAREHOLDERS
Source text for Eikon: ID:nASX1JBTRm
Further company coverage: CAN.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Rua Bioscience
See all newsBrief: Rua Bioscience Reports Research Partnership To Develop Smoking Cessation Products
Brief: Rua Bioscience Secures Exclusive NZ Distribution Rights For Medical Device
NZ's Rua Bioscience rises on securing exclusive dsitribution for medical device
Brief: Rua Bioscience Secures New Long-Term Supply Arrangement In Germany
NZ's Rua Bioscience falls to over three-month low on discounted capital raising